XML 39 R29.htm IDEA: XBRL DOCUMENT v3.25.2
REVENUE RECOGNITION AND RELATED ALLOWANCES (Tables)
 6 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of disaggregation of revenue and revenue recognized
All revenue recognized in the accompanying unaudited condensed consolidated statements of operations is considered to be revenue from contracts with customers. The following table depicts the disaggregation of revenue:
Three Months Ended June 30,Six Months Ended June 30,
Products and Services (in thousands)2025202420252024
Rare Disease and Brands
Cortrophin Gel$81,647 $49,193 $134,497 $86,130 
ILUVIEN and YUTIQ22,316 — 38,425 — 
Rare Disease total net revenues$103,963 $49,193 $172,922 $86,130 
Brands13,195 10,027 38,318 35,706 
Rare Disease and Brands total net revenues$117,158 $59,220 $211,240 $121,836 
Generics and Other
Generic pharmaceutical products$90,297 $73,964 $188,975 $144,181 
Royalties and other pharmaceutical services3,916 4,856 8,278 9,453 
Generics and Other total net revenues94,213 78,820 197,253 153,634 
Total net revenues$211,371 $138,040 $408,493 $275,470 
Schedule of accruals and allowances
The following table summarizes activity in the unaudited condensed consolidated balance sheets for accruals and allowances for the six months ended June 30, 2025 and 2024, respectively:
Accruals for Chargebacks, Returns, and Other Allowances
(in thousands)ChargebacksGovernment
Rebates		ReturnsAdministrative
Fees and Other
Rebates		Prompt
Payment
Discounts
Balance at December 31, 2023$84,208 $12,168 $29,678 $11,412 $4,865 
Accruals/Adjustments267,779 13,324 21,895 29,970 11,422 
Credits Taken Against Reserve(262,541)(13,168)(17,676)(29,656)(11,243)
Balance at June 30, 2024 (1)$89,446 $12,324 $33,897 $11,726 $5,044 
Balance at December 31, 2024$105,630 $18,714 $39,274 $19,588 $6,258 
Accruals/Adjustments330,581 32,910 22,737 40,730 17,134 
Credits Taken Against Reserve(337,311)(18,758)(13,328)(38,902)(17,090)
Balance at June 30, 2025 (1)$98,900 $32,866 $48,683 $21,416 $6,302 
______________________________________________
(1)Chargebacks are included as an offset to accounts receivable, net of chargebacks and other allowances in the unaudited condensed consolidated balance sheets. Administrative Fees and Other Rebates and Prompt Payment Discounts are included as a reduction to accounts receivable, net of chargebacks and other allowances or accrued expenses and other in the unaudited condensed consolidated balance sheets. Returns are included in returned goods reserve in the unaudited condensed consolidated balance sheets. Government Rebates are included in accrued government rebates in the unaudited condensed consolidated balance sheets.
Schedule of customer concentration
The four customers represent the total percentage of net revenues as follows:
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Customer 118 %24 %21 %29 %
Customer 29 %12 %10 %12 %
Customer 311 %13 %12 %11 %
Customer 420 %17 %18 %15 %